Perticipation of IL-18 in human cholestatic cirrhosis and acute rejection - Analysis in living donor liver transplantation

Takahito Yagi, Hiromi Iwagaki, Naoto Urushihara, Masahiro Oishi, Kenta Kobashi, Hideo Kohka, Hiroshi Sadamori, Masaru Inagaki, Norihisa Takakura, Toshihiro Higashi, Takao Tsuji, Tadashi Yoshino, Tadao Tanimoto, Masashi Kurimoto, Noriaki Tanaka

Research output: Contribution to journalArticle

Abstract

We herein report the relationship between IL-18 and pathogenesis in patients who have cholestatic cirrhosis and acute rejection after living donor liver transplantation. Twenty-one healthy volunteers (control) and patients with obstructive jaundice (OBJ, n = 4), endostage PBC (PBC, n = 7), biliary atresia after failed Kasai's operation (BATx, n = 4) and biliary atresia after successful Kasai's operation (BANTx, n = 4) were examined. Altough serum IL-18 levels were closely correlated with total bilirubin levels in these patients, there were significant differences in sIL-18 levels between OBJ and PBC plus BA group. In all groups, hyper IL-18nemia was not accompanied by IFN-γ production. Since 6 patients (2 PBC and 4 BATx) underwent living donor liver transplantation. (LDLT) , post-transplant cytokine producing profiles including IFN-γ , IL-6, -10, -12, -18 were determined. After LDLT, IFN-γ levels in recipients'serum were increased and IFN-γ producing property of recipients was improved. Furthermore, sIL-18 levels were closely related with rejectional episodes after LDLT. IL-18 may be a key substance which regulates development of human cholestatic liver diseases and rejection after liver transplantation.

Original languageEnglish
Pages (from-to)85-92
Number of pages8
JournalJapanese Pharmacology and Therapeutics
Volume27
Issue numberSUPPL. 7
Publication statusPublished - Dec 1999

Fingerprint

Living Donors
Liver Transplantation
Interleukin-18
Fibrosis
Biliary Atresia
Obstructive Jaundice
Human Development
Serum
Bilirubin
Interleukin-10
Liver Diseases
Interleukin-6
Healthy Volunteers
Cytokines
Transplants
Rejection (Psychology)
human interleukin 18 protein

Keywords

  • Acute rejection
  • Cholestatic cirrhosis
  • IL-18

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Yagi, T., Iwagaki, H., Urushihara, N., Oishi, M., Kobashi, K., Kohka, H., ... Tanaka, N. (1999). Perticipation of IL-18 in human cholestatic cirrhosis and acute rejection - Analysis in living donor liver transplantation. Japanese Pharmacology and Therapeutics, 27(SUPPL. 7), 85-92.

Perticipation of IL-18 in human cholestatic cirrhosis and acute rejection - Analysis in living donor liver transplantation. / Yagi, Takahito; Iwagaki, Hiromi; Urushihara, Naoto; Oishi, Masahiro; Kobashi, Kenta; Kohka, Hideo; Sadamori, Hiroshi; Inagaki, Masaru; Takakura, Norihisa; Higashi, Toshihiro; Tsuji, Takao; Yoshino, Tadashi; Tanimoto, Tadao; Kurimoto, Masashi; Tanaka, Noriaki.

In: Japanese Pharmacology and Therapeutics, Vol. 27, No. SUPPL. 7, 12.1999, p. 85-92.

Research output: Contribution to journalArticle

Yagi, T, Iwagaki, H, Urushihara, N, Oishi, M, Kobashi, K, Kohka, H, Sadamori, H, Inagaki, M, Takakura, N, Higashi, T, Tsuji, T, Yoshino, T, Tanimoto, T, Kurimoto, M & Tanaka, N 1999, 'Perticipation of IL-18 in human cholestatic cirrhosis and acute rejection - Analysis in living donor liver transplantation', Japanese Pharmacology and Therapeutics, vol. 27, no. SUPPL. 7, pp. 85-92.
Yagi, Takahito ; Iwagaki, Hiromi ; Urushihara, Naoto ; Oishi, Masahiro ; Kobashi, Kenta ; Kohka, Hideo ; Sadamori, Hiroshi ; Inagaki, Masaru ; Takakura, Norihisa ; Higashi, Toshihiro ; Tsuji, Takao ; Yoshino, Tadashi ; Tanimoto, Tadao ; Kurimoto, Masashi ; Tanaka, Noriaki. / Perticipation of IL-18 in human cholestatic cirrhosis and acute rejection - Analysis in living donor liver transplantation. In: Japanese Pharmacology and Therapeutics. 1999 ; Vol. 27, No. SUPPL. 7. pp. 85-92.
@article{60b6f8d820294c688b5faf326052751f,
title = "Perticipation of IL-18 in human cholestatic cirrhosis and acute rejection - Analysis in living donor liver transplantation",
abstract = "We herein report the relationship between IL-18 and pathogenesis in patients who have cholestatic cirrhosis and acute rejection after living donor liver transplantation. Twenty-one healthy volunteers (control) and patients with obstructive jaundice (OBJ, n = 4), endostage PBC (PBC, n = 7), biliary atresia after failed Kasai's operation (BATx, n = 4) and biliary atresia after successful Kasai's operation (BANTx, n = 4) were examined. Altough serum IL-18 levels were closely correlated with total bilirubin levels in these patients, there were significant differences in sIL-18 levels between OBJ and PBC plus BA group. In all groups, hyper IL-18nemia was not accompanied by IFN-γ production. Since 6 patients (2 PBC and 4 BATx) underwent living donor liver transplantation. (LDLT) , post-transplant cytokine producing profiles including IFN-γ , IL-6, -10, -12, -18 were determined. After LDLT, IFN-γ levels in recipients'serum were increased and IFN-γ producing property of recipients was improved. Furthermore, sIL-18 levels were closely related with rejectional episodes after LDLT. IL-18 may be a key substance which regulates development of human cholestatic liver diseases and rejection after liver transplantation.",
keywords = "Acute rejection, Cholestatic cirrhosis, IL-18",
author = "Takahito Yagi and Hiromi Iwagaki and Naoto Urushihara and Masahiro Oishi and Kenta Kobashi and Hideo Kohka and Hiroshi Sadamori and Masaru Inagaki and Norihisa Takakura and Toshihiro Higashi and Takao Tsuji and Tadashi Yoshino and Tadao Tanimoto and Masashi Kurimoto and Noriaki Tanaka",
year = "1999",
month = "12",
language = "English",
volume = "27",
pages = "85--92",
journal = "Japanese Pharmacology and Therapeutics",
issn = "0386-3603",
publisher = "Life Science Publishing Co. Ltd",
number = "SUPPL. 7",

}

TY - JOUR

T1 - Perticipation of IL-18 in human cholestatic cirrhosis and acute rejection - Analysis in living donor liver transplantation

AU - Yagi, Takahito

AU - Iwagaki, Hiromi

AU - Urushihara, Naoto

AU - Oishi, Masahiro

AU - Kobashi, Kenta

AU - Kohka, Hideo

AU - Sadamori, Hiroshi

AU - Inagaki, Masaru

AU - Takakura, Norihisa

AU - Higashi, Toshihiro

AU - Tsuji, Takao

AU - Yoshino, Tadashi

AU - Tanimoto, Tadao

AU - Kurimoto, Masashi

AU - Tanaka, Noriaki

PY - 1999/12

Y1 - 1999/12

N2 - We herein report the relationship between IL-18 and pathogenesis in patients who have cholestatic cirrhosis and acute rejection after living donor liver transplantation. Twenty-one healthy volunteers (control) and patients with obstructive jaundice (OBJ, n = 4), endostage PBC (PBC, n = 7), biliary atresia after failed Kasai's operation (BATx, n = 4) and biliary atresia after successful Kasai's operation (BANTx, n = 4) were examined. Altough serum IL-18 levels were closely correlated with total bilirubin levels in these patients, there were significant differences in sIL-18 levels between OBJ and PBC plus BA group. In all groups, hyper IL-18nemia was not accompanied by IFN-γ production. Since 6 patients (2 PBC and 4 BATx) underwent living donor liver transplantation. (LDLT) , post-transplant cytokine producing profiles including IFN-γ , IL-6, -10, -12, -18 were determined. After LDLT, IFN-γ levels in recipients'serum were increased and IFN-γ producing property of recipients was improved. Furthermore, sIL-18 levels were closely related with rejectional episodes after LDLT. IL-18 may be a key substance which regulates development of human cholestatic liver diseases and rejection after liver transplantation.

AB - We herein report the relationship between IL-18 and pathogenesis in patients who have cholestatic cirrhosis and acute rejection after living donor liver transplantation. Twenty-one healthy volunteers (control) and patients with obstructive jaundice (OBJ, n = 4), endostage PBC (PBC, n = 7), biliary atresia after failed Kasai's operation (BATx, n = 4) and biliary atresia after successful Kasai's operation (BANTx, n = 4) were examined. Altough serum IL-18 levels were closely correlated with total bilirubin levels in these patients, there were significant differences in sIL-18 levels between OBJ and PBC plus BA group. In all groups, hyper IL-18nemia was not accompanied by IFN-γ production. Since 6 patients (2 PBC and 4 BATx) underwent living donor liver transplantation. (LDLT) , post-transplant cytokine producing profiles including IFN-γ , IL-6, -10, -12, -18 were determined. After LDLT, IFN-γ levels in recipients'serum were increased and IFN-γ producing property of recipients was improved. Furthermore, sIL-18 levels were closely related with rejectional episodes after LDLT. IL-18 may be a key substance which regulates development of human cholestatic liver diseases and rejection after liver transplantation.

KW - Acute rejection

KW - Cholestatic cirrhosis

KW - IL-18

UR - http://www.scopus.com/inward/record.url?scp=24144473087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24144473087&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:24144473087

VL - 27

SP - 85

EP - 92

JO - Japanese Pharmacology and Therapeutics

JF - Japanese Pharmacology and Therapeutics

SN - 0386-3603

IS - SUPPL. 7

ER -